R1626C (p.Arg1626Cys) variant of SCN5A (Nav1.5)
R1626C (p.Arg1626Cys) in SCN5A (Nav1.5) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Cardiovascular phenotype; Cardiac arrhythmia; Long QT syndrome 3. The available variant effect predictions contribute to a CATVariant prioritization score of 0.91 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.
R1626C (p.Arg1626Cys) variant details
- p.Arg1626Cys
- rs918933961
- ClinGen CA16611263
- NCI-TCGA Cosmic COSV6111
- cosmic curated COSV61118
- Conflicting interpretations
- Cardiovascular phenotype; Cardiac arrhythmia; Long QT syndrome 3
- Missense
- Variant Prioritization Score for Impact Estimate 0.909
- ESM-1b 1.00
- AlphaMissense 1.00
- MetaLR 0.99
- MetaSVM 0.97
- CADD 32.00
- PolyPhen-2 1.00
- ClinVar: Conflicting classifications of pathogenicity (Cardiac arrhythmia; Cardiovascular phenotype; SUDDEN INFANT DEAT)
- EBI: Likely pathogenic (in LQT3)
- UniProt: Likely pathogenic (in LQT3)
- Population evidence available
- Structural context available
- SCN5A response to veratridine+brevetoxin+ouabain mixture: score 78.3
- Cited in: Brugada Syndrome. (PMID 20301690)
- Cited in: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this… (PMID 21810866)